Know Cancer

forgot password

Cervical Video Assisted Thoracoscopic Surgery (C-VATS)Using a Flexible Endoscope for Thoracoscopy

18 Years
Open (Enrolling)
Lung Cancer

Thank you

Trial Information

Cervical Video Assisted Thoracoscopic Surgery (C-VATS)Using a Flexible Endoscope for Thoracoscopy

Hypothesis: C-VATS is a feasible and safe method of entering the pleural space in order to
perform pleural evaluation, pleural biopsy and pleurodesis in patients with pleural disease
and/or pleural effusions.

Objectives: Evaluate the safety and feasibility of C-VATS in patients with pleural disease.

Design: Prospective, cohort, feasibility and safety study.

Methods: Patients referred to all thoracic surgeons in the Division of Thoracic Surgery at
the CHUM Notre Dame campus for the diagnosis or treatment of pleural based diseases will be
screened for enrolment. The investigators plan to recruit 10 patients in this initial study.
Eligible patients will be consented by one of the thoracic surgeons at the CHUM.

All procedures will be performing in the operating room at the CHUM Notre Dame Hospital. All
patients will be admitted prior to their procedure and treated on the post-operative
thoracic surgery ward using standard post-VATS procedural treatments. All cause, as well as
procedure specific morbidity will be recorded by the study investigators on the day of the
procedure, every day in hospital until discharge and at 1 week, 4 weeks and 12 weeks post

Inclusion Criteria:

- Eligible patients will be those that would be candidates for the same pleural
procedure (biopsy, drainage and pleurodesis) using a VATS technique

Exclusion Criteria:

- Anticoagulation including Warfarin, Heparin or Clopidogrel which cannot be stopped

- Patients less than 18 years old

- Pregnant patients

- Patient unable to extend neck fully

- Patients with cervical spine instability

- Patients having had previous neck or mediastinal surgery which would preclude

- Patients having previously undergone mediastinal irradiation

- Patients having been previously diagnosed with mediastinitis

- Active cervical cutaneous or deep cervical infections

Type of Study:


Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

procedure-related morbidity

Outcome Description:

Intra-operative mortality In-hospital mortality 30-day mortality

Outcome Time Frame:

30 days

Safety Issue:


Principal Investigator

Moishe Liberman, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Centre de Recherche du Centre Hospitalier de l'Université de Montréal


Canada: Ethics Review Committee

Study ID:

CE 11.092



Start Date:

September 2011

Completion Date:

February 2014

Related Keywords:

  • Lung Cancer
  • mediastinoscopy
  • pleural evaluation
  • pleural biopsy
  • pleurodesis
  • Lung Neoplasms